GH treated breast cancer cells MDA-MB-435S and T47D, as well as endometrial cancer cell RL95-2 showed markedly reduced DNA damage as well as heightened clonogenic survival post-irradiation[177]. This evidence concerns the gene GH1 and breast carcinoma.